Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NXTC compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
NXTC
NextCure, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
NXTC
NextCure, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
NXTC: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NXTC
7
—
LigaChem Biosciences, Inc., formerly known as LegoChem Biosciences, Inc ("LigaChem")
unlisted
supplier
—
Simcere Zaiming Pharmaceutical Co., Ltd. (formerly known as Hainan Simcere Zaiming Pharmaceutical, Ltd. or hereinafter "Zaiming")
unlisted
supplier
—
WuXi XDC
unlisted
supplier
—
Yale University ("Yale")
unlisted
supplier
3 more · NXTC chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NXTC, solid
LLY, dashed
NXTC
NextCure, Inc.
Change
5.88
▲
+3.25%
Mkt cap
$28.9M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,417.45
▲
+0.57%
Regular session
Nov 4 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 4 '26
NXTC
NextCure, Inc.
vs
LLY
ELI Lilly & Co
5.88
▲
+3.25%
Price
1,417.45
▲
+0.57%
$28.9M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
NXTC
5.88
▲
+3.25%
vs
LLY
1,417.45
▲
+0.57%
Regular session
Nov 4 '26